Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | GLA | P06280 | 1/20 | 0.40 |
| ▸ | CNR2 | P34972 | 2/20 | 0.39 |
| ▸ | PPARG | P37231 | 3/20 | 0.39 |
| ▸ | F10 | P00742 | 1/20 | 0.37 |
| ▸ | PLA2G2A | P14555 | 2/20 | 0.36 |
| ▸ | TSPO | P30536 | 1/20 | 0.36 |
| ▸ | PPARA | Q07869 | 1/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | IDO1 | P14902 | 1/20 | 0.35 |
| ▸ | DRD2 | P14416 | 1/20 | 0.35 |
| ▸ | HTR6 | P50406 | 1/20 | 0.35 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5212214 | 0.90 | PPARG (0.46) | PPARGPLA2G2APPARA | |
| SCHEMBL6770304 | 0.90 | CNR1 (0.42) | CNR2PPARGF10PLA2G2APPARA | |
| SCHEMBL6774816 | 0.89 | LMNA (0.43) | LMNAGLAF10PLA2G2ATSPO | |
| SCHEMBL6889327 | 0.89 | MAPT (0.41) | LMNAGLACNR2F10POLB | |
| SCHEMBL6774931 | 0.89 | PLA2G2A (0.48) | CNR2PPARGPLA2G2A | |
| SCHEMBL6773827 | 0.89 | PPARG (0.39) | PPARGF10PLA2G2APPARAPOLB | |
| SCHEMBL6781743 | 0.88 | TRPV1 (0.45) | LMNAPPARGF10POLBMAPK8 | |
| SCHEMBL6781319 | 0.88 | PPARG (0.42) | CNR2PPARGF10PLA2G2APPARA | |
| SCHEMBL6776320 | 0.88 | PPARG (0.41) | CNR2PPARGPLA2G2APPARA | |
| SCHEMBL6776550 | 0.86 | ADRA1D (0.41) | PPARGPLA2G2APPARAPOLBMAPK8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6713645-B1 | INHIBITING SPLA2 MEDIATED RELEASE OF FATTY ACIDS FOR TREATMENT OF CONDITIONS SUCH AS SEPTIC SHOCK | ELI LILLY AND COMPANY | 2004-03-30 | — | — | US | disclosed |
| US-6177440-B1 | THERAPY FOR SEPSIS SHOCK; PHOSPHOLIPASE INHBITOR | ELI LILLY AND COMPANY | 2001-01-23 | — | — | US | disclosed |
| EP-0952149-A2 | Substituted carbazoles, process for their preparation and their use as sPLA2 inhibitiors | ELI LILLY AND COMPANY (US) | 1999-10-27 | — | — | EP | disclosed |